Non-Small Cell Lung Cancer Harboring Concurrent <i>EGFR</i> Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma

• Main Authors: Valerio Gristina (Author), Maria La Mantia (Author), Antonio Galvano (Author), Sofia Cutaia (Author), Nadia Barraco (Author), Marta Castiglia (Author), Alessandro Perez (Author), Marco Bono (Author), Federica Iacono (Author), Martina Greco (Author), Katia Calcara (Author), Valentina Calò (Author), Sergio Rizzo (Author), Lorena Incorvaia (Author), Maria Chiara Lisanti (Author), Giulia Santanelli (Author), Delia Sardo (Author), Sara Inguglia (Author), Lavinia Insalaco (Author), Luisa Castellana (Author), Stefania Cusenza (Author), Gianni Pantuso (Author), Antonio Russo (Author), Viviana Bazan (Author)
• Format: Book
• Published: MDPI AG, 2021-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

The molecular pathways which promote lung cancer cell features have been broadly explored, leading to significant improvement in prognostic and diagnostic strategies. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) have dramatically altered the treatment approach for patien...